Switch Bioworks Awarded $2M in Federal Funding for Technology to Reduce Synthetic Nitrogen Fertilizer in Crop Production
The grant will catalyze and expand Switch Bioworks' R&D, which is centered on enabling nitrogen-fixing microbes to compete and establish themselves on crop plant roots before switching to fertilizer production – an industry-wide challenge that has been limiting biofertilizer cost and performance. The product will be applied at planting with existing farmer practices and have superior unit economics and sustainability benefits over traditional fertilizers.
"Engineering commercially relevant biological nitrogen fixation for cereal crops like corn has challenged scientists for over 50 years," said Founder and CEO of Switch Bioworks, Dr.
Switch Bioworks' project is one of nine selected for funding under ARPA-E's program: Technologies to Emend and Obviate Synthetic Nitrogen's Toll on Emissions (TEOSYNTE). This program supports the development of new technologies that lower nitrous oxide emissions, a greenhouse gas from nitrogen fertilizers with a global warming potential over 250 times higher than carbon dioxide.
"We are delighted to have been selected to participate in this ambitious ARPA-E program," says Principal Investigator Dr.
Nearly half of
About Switch Bioworks
Switch Bioworks, the living fertilizer company, was founded out of Stanford University in 2022 and is headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/switch-bioworks-awarded-2m-in-federal-funding-for-technology-to-reduce-synthetic-nitrogen-fertilizer-in-crop-production-302352781.html
SOURCE Switch Bioworks
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paratus Energy: Ex Dividend USD 0.22 per share today
- Eluvio Showcases New Advanced Features in Global Broadcast Fabric for Zero-Copy Broadcast Distribution, D2C OTT Streaming & Monetization, and Inline AI Video Intelligence at IBC 2026
- ONWARD Medical Announces First Implant in New Clinical Feasibility Study Evaluating ARC-IM System to Restore Mobility After Spinal Cord Injury
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share